Tag Archives: Hemophilia B

FDA Approves Hemgenix- World’s First Gene Therapy for Adults with Hemophilia B

On November 22, 2022, the U.S. FDA approved Hemgenix (Etranacogene Dezaparvovec; CSL Behring LLC.) for treating adults with Hemophilia B […]

ikrisuser
November 24, 2022